DLTR
38
4
BWA
46
2
FITB
60
2
RL
68
3
FLR
55
6
FOXA
59
4
CFG
64
2
GOOG
53
-12
SBUX
39
3
MRK
27
5
TGNA
56
3
ADI
47
2
IBM
60
6
ICE
62
3
ORCL
67
2
DVN
18
2
CAT
62
7
ALLE
44
7
EXC
56
2
HBAN
56
2
DLTR
38
4
BWA
46
2
FITB
60
2
RL
68
3
FLR
55
6
FOXA
59
4
CFG
64
2
GOOG
53
-12
SBUX
39
3
MRK
27
5
TGNA
56
3
ADI
47
2
IBM
60
6
ICE
62
3
ORCL
67
2
DVN
18
2
CAT
62
7
ALLE
44
7
EXC
56
2
HBAN
56
2
Financhill
Back

Anebulo Pharmaceuticals Vs. Revance Therapeutics Industry Stock Comparison

Sell
38

ANEB
Anebulo Pharmaceuticals

Last Price:
1.59
Seasonality Move:
11.06%
Sell
10

RVNC
Revance Therapeutics

Last Price:
3.73
Seasonality Move:
2.15%
Sell
38
Anebulo Pharmaceuticals (ANEB) is a Sell

Is Anebulo Pharmaceuticals a Buy, Sell or Hold?

  • The current Anebulo Pharmaceuticals [ANEB] share price is $1.50. The Score for ANEB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ANEB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.84. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ANEB Stock Price Chart

What is Anebulo Pharmaceuticals's stock price today?

  • The Anebulo Pharmaceuticals share price today is $1.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANEB is experiencing slight buying pressure.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight buying pressure.

ANEB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 38.24 Sell
Chaikin Money Flow: 2262 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.57 - 1.89) Sell
Bollinger Bands (100): (1.73 - 2.27) Sell

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 34.28 Sell
Chaikin Money Flow: 227722 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.06 - 5.8) Sell
Bollinger Bands (100): (3.74 - 6.28) Sell

ANEB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.55 Sell
20-day SMA: 1.69 Sell
50-day SMA: 1.88 Sell
200-day SMA: 2.29 Sell
8-day EMA: 1.55 Sell
20-day EMA: 1.66 Sell
50-day EMA: 1.81 Sell
200-day EMA: 2.17 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.03 Sell
20-day SMA: 4.84 Sell
50-day SMA: 5.22 Sell
200-day SMA: 4.61 Sell
8-day EMA: 4.07 Sell
20-day EMA: 4.56 Sell
50-day EMA: 4.97 Sell
200-day EMA: 6.03 Sell

Anebulo Pharmaceuticals Earnings Growth & ANEB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.09 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

Anebulo Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):